NCT03813147 2025-04-13Pevonedistat, Azacitidine, Fludarabine Phosphate, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic SyndromeNational Cancer Institute (NCI)Phase 1 Completed12 enrolled 16 charts